Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

EEG and ANI Guided Anesthesia and Quality of Recovery

NCT: NCT05936671 · RECRUITING

NCT IDNCT05936671
StatusRECRUITING
Start Date2023-07-13
Completion2027-06-25
SponsorGangnam Severance Hospital (OTHER)
First posted
Last updated

Brief Summary

This study aims to assess whether electroencephalogram (EEG) and nociception level-guided anesthesia can improve quality of recovery after laparoscopic gynecological surgery compared with standard care. Patients will be randomly assigned to either EEG and Analgesia Nociception Index (ANI)-guided anesthesia group (EEG-and-ANI-Guided group) or usual care group (control group). Primary outcome is 15-item Quality of Recovery (QoR-15) score at postoperative day (POD) 1. Secondary outcomes included remifentanil consumption during anesthesia, occurrence of awareness with recall, incidence of undesirable intraoperative movement, emergence time, postoperative pain scores, quality of recovery score at POD 2, and length of hospital stay.

Frequently Asked Questions

What is EEG and ANI Guided Anesthesia and Quality of Recovery?

EEG and ANI Guided Anesthesia and Quality of Recovery is a clinical trial registered under NCT05936671. Current status: RECRUITING.

What is the status of NCT05936671?

The current status of NCT05936671 (EEG and ANI Guided Anesthesia and Quality of Recovery) is: RECRUITING.

When did EEG and ANI Guided Anesthesia and Quality of Recovery start?

EEG and ANI Guided Anesthesia and Quality of Recovery started on 2023-07-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.